Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Drug Monitoring of Asparaginase Activity to Detect Silent Inactivation in Pediatric Acute Lymphoblastic Leukemia Patients Receiving Peg-Asparaginase

Van Thu Huynh, MD, Alexa Love, BA, Mary English, CPNP, Carol Hwang Lin, MD

Blood (2018) 132 (Supplement 1): 3968.

https://doi.org/10.1182/blood-2018-99-117165

Published: 2018

Journal Articles

Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability

Anupam Verma, MD, Karin Chen, MD, Jacob Johnsen, PharmD, Phillip Barnette, MD

Blood (2018) 132 (Supplement 1): 5205.

https://doi.org/10.1182/blood-2018-99-119866

Published: 2018

Journal Articles

Decrease of Asparaginase Induced Thrombotic Events with Antithrombin III Monitoring and Repletion

Kyle Grose, PharmD, Jeremy M Sen, PharmD, BCOP, Amy L Morris, PharmD, Kathlene DeGregory, PharmD, BCOP, Surabhi Palkimas, PharmD, Michael G. Douvas, MD

Blood (2018) 132 (Supplement 1): 1381.

https://doi.org/10.1182/blood-2018-99-116744

Published: 2018

Journal Articles

Feasibility and Outcome of Late Intensification with Native L-Asparaginase for Acute Lymphoblastic Leukemia in the Elderly: A Single Center Experience

Francois Xavier Gros, MD, Pierre-Yves Dumas, MD, Edouard Forcade, MD, Claire Calmettes, MD, Margot Robles, MD, Vincent Servant, PharmD, Nicolas Lechevalier, PharmD, Audrey Bidet, PharmD, Noel Milpied, Arnaud Pigneux, MD PhD, Thibaut Leguay, MD

Blood (2017) 130 (Supplement 1): 1296.

https://doi.org/10.1182/blood.V130.Suppl_1.1296.1296

Published: 2017

Journal Articles

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Katie Zomorodi, PhD, Todd Dumas, PharmD, Seth Berry, PharmD, Curtis Johnston, PharmD, Mark Eller, PhD

Blood (2016) 128 (22): 1631.

https://doi.org/10.1182/blood.V128.22.1631.1631

Published: 2016

Journal Articles

Intravenous and Intramuscular Administration of Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Perceptions

Celine Bernard, MBA, Megan P. Hall, PhD, Tina Doede, MS, MBA

Blood (2015) 126 (23): 4914.

https://doi.org/10.1182/blood.V126.23.4914.4914

Published: 2015

Journal Articles

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Chitose Ogawa, MD, Atsushi Manabe, MD PhD, Hiroaki Goto, MD PhD, Katsuyoshi Koh, MD, Daisuke Tomizawa, MD PhD, Keitaro Fukushima, MD PhD, Ken-ichiro Watanabe, MD PhD, Keizo Horibe, MD, Atsushi Kikuta, MD PhD, Mitsuma Hamada, PhD, Akira Ohara, MD PhD

Blood (2014) 124 (21): 3657.

https://doi.org/10.1182/blood.V124.21.3657.3657

Published: 2014

Journal Articles

Nanoparticle Encapsulated L-Asparaginase

Inanc Ortac, Laura Ruff, Yasan Yeh, Sadik Esener, Bradley T Messmer, PhD

Blood (2013) 122 (21): 2669.

https://doi.org/10.1182/blood.V122.21.2669.2669

Published: 2013

Journal Articles

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Lynda M. Vrooman, MD, Ivan I. Kirov, MD, Zoann E. Dreyer, MD, Michael Kelly, MD, PhD, Nobuko Hijiya, MD, Patrick Brown, MD, Richard A. Drachtman, MD, Yoav H Messinger, MD, A. Kim Ritchey, MD, Gregory A. Hale, MD, Kelly Maloney, MD, Paul V. Plourde, MD, Lewis B. Silverman, MD

Blood (2013) 122 (21): 3904.

https://doi.org/10.1182/blood.V122.21.3904.3904

Published: 2013

Journal Articles

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol.

Paul V. Plourde, MD, Sima Jeha, MD, Nobuko Hijiya, MD, Frank G Keller, MD, Susan R. Rheingold, MD, Zoann E. Dreyer, MD, Gary V. Dahl, MD, Taheri Mercedes, MD, Tim Corn, MD

Blood (2012) 120 (21): 2568.

https://doi.org/10.1182/blood.V120.21.2568.2568

Published: 2012

Journal Articles

Anti-Leukemic Activity of a Novel Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase On Lymphoid Cell Lines and Leukemia-Bearing Mouse Models.

Wei-Wen Chien, PhD, Céline Lebeux, Nicolas Rachinel, PhD, Soraya Allas, MD, PhD, Pierre Sahakian, Pharm PhD, Michel Julien, PhD, Claire Lacroix, Thierry Abribat, PhD, Gilles Salles, MD

Blood (2012) 120 (21): 2571.

https://doi.org/10.1182/blood.V120.21.2571.2571

Published: 2012

Journal Articles

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Wanda Salzer, MD, Barbara Asselin, MD, Jeffrey Supko, PhD, Meenakshi Devidas, PhD, Nicole Kaiser, RPh, Paul V. Plourde, MD, Naomi Winick, MD, Gregory Reaman, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen Hunger, MD

Blood (2010) 116 (21): 2134.

https://doi.org/10.1182/blood.V116.21.2134.2134

Published: 2010

Journal Articles

Adverse Reactions to PEG and Erwinia Asparaginase and Correlation with Anti-Asparaginase Antibody Data and Survival in Children with Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group Study CCG 1961.

Girish Dhall, M.D., Tamekia Jones, PhD, David Radvinsky, Nathan Robison, MD, Anna Butturini, MD, Joan I Rubin, RN, Paul S. Gaynon, MD, Eduard H Panosyan, MD, Ioannis A Avramis, Vassilios I Avramis, PhD, Lawrence J. Ettinger, MD, Nita L. Seibel, MD

Blood (2009) 114 (22): 3077.

https://doi.org/10.1182/blood.V114.22.3077.3077

Published: 2009

Journal Articles

Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD

Blood (2009) 114 (22): 2033.

https://doi.org/10.1182/blood.V114.22.2033.2033

Published: 2009

Journal Articles

Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD

Blood (2009) 114 (22): 2034.

https://doi.org/10.1182/blood.V114.22.2034.2034

Published: 2009

NARROW

Drug Monitoring of Asparaginase Activity to Detect Silent Inactivation in Pediatric Acute Lymphoblastic Leukemia Patients Receiving Peg-Asparaginase

Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability

Decrease of Asparaginase Induced Thrombotic Events with Antithrombin III Monitoring and Repletion

Feasibility and Outcome of Late Intensification with Native L-Asparaginase for Acute Lymphoblastic Leukemia in the Elderly: A Single Center Experience

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Intravenous and Intramuscular Administration of Asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia: Treatment Patterns and Perceptions

Phase I/II Clinical Trial of Erwinia Asparaginase (Erwinase R ) in Combination with Prednisolone, Vincristine and Pirarubicin in Children and Young Adults with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Nanoparticle Encapsulated L-Asparaginase

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

L-Asparaginase (L-ASP) Related Toxicities with Asparaginase Erwinia Chrysanthemi in a Large Compassionate Use Protocol.

Anti-Leukemic Activity of a Novel Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase On Lymphoid Cell Lines and Leukemia-Bearing Mouse Models.

Administration of Erwinia Asparaginase (Erwinase®) Following Allergy to PEG-Asparaginase In Children and Young Adults with Acute Lymphoblastic Leukemia Treated on AALL07P2 Achieves Therapeutic Nadir Serum Asparaginase Activity: A Report From the Children's Oncology Group (COG)

Adverse Reactions to PEG and Erwinia Asparaginase and Correlation with Anti-Asparaginase Antibody Data and Survival in Children with Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group Study CCG 1961.

Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only